Nigeria Legalized Cannabis Market Size & Outlook, 2025-2033
Nigeria Legalized Cannabis Market Insights
- Reed Intelligence analysis indicates that the Nigeria Legalized Cannabis Market size, valued at USD 259.13 Million in 2024, is expected to expand to USD 2203.42 Million by 2033.
- The Nigeria market is forecasted to expand at a CAGR of 26.7% spanning 2025–2033.
- Medical held the leading position among By Usage segments in 2024, based on market size.
- Medical is projected to post the fastest growth rate, sustaining its position as the most attractive By Usage segment during the forecast horizon.
![Nigeria Legalized Cannabis Market Size, Share & Growth Report By [2033]](https://reedintelligence.com/uploads/charts/nigeria-legalized-cannabis-market-nigeria-by-usage-44694.png)
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- Nigeria accounted for 0.76% of the global Legalized Cannabis Market size in 2024.
- By 2033, United States is expected to remain the top global market in terms of size.
- Within Middle East and Africa, United Arab Emirates is forecasted to dominate the regional Legalized Cannabis Market size by 2033.
- Nigeria will be the fastest-growing market in Middle East and Africa, projected to achieve USD 2180.25 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 259.13 Million |
| Market Size In 2033 | USD 2203.42 Million |
| Largest segment | Medical |
| Units | Revenue in USD Million |
| CAGR | 26.7% (2025-2033) |
| Segmnetation Covered | |
| By Usage |
|
| By Form |
|
| By Application |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Nigeria Legalized Cannabis Market By Usage 2025-2033 (USD Million)
| By Usage | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical | XX.x | XX.x | XX.x | 129.93 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Recreational | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Industrial Hemp | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Nigeria Legalized Cannabis Market By Form 2025-2033 (USD Million)
| By Form | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bud | XX.x | XX.x | XX.x | 129.07 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Oil | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Tincture | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Nigeria Legalized Cannabis Market By Application 2025-2033 (USD Million)
| By Application | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic Pain | XX.x | XX.x | XX.x | 112.67 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Mental Disorders | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Cancer | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Others | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
